Schütt, M <br/><br/>
The HIV protease inhibitor indinavir impairs glycogen synthesis in HepG2 hepatoma cells.  [electronic resource] 

 -  Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association  Feb 2003 
 - 16-20 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0947-7349 
<br/><br/><label>Standard No.: </label>10.1055/s-2003-37495  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Carcinoma, Hepatocellular--enzymology<br/>Glucose--metabolism<br/>Glycogen--biosynthesis<br/>HIV Protease Inhibitors--pharmacology<br/>Humans<br/>Hypoglycemic Agents--pharmacology<br/>Indinavir--pharmacology<br/>Insulin--pharmacology<br/>Liver--drug effects<br/>Liver Neoplasms--enzymology<br/>Protein Tyrosine Phosphatases--metabolism<br/>Stimulation, Chemical<br/>Tumor Cells, Cultured